Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Standard Biotools (LAB) Accumulated Depreciation & Amortization (2016 - 2026)

Standard Biotools has reported Accumulated Depreciation & Amortization over the past 15 years, most recently at $47.3 million for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 284.24% to $47.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $47.3 million through Dec 2025, up 284.24% year-over-year, with the annual reading at $47.3 million for FY2025, 284.24% up from the prior year.
  • Accumulated Depreciation & Amortization was $47.3 million for Q4 2025 at Standard Biotools, up from $46.7 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $70.1 million in Q1 2025 and troughed at $2.8 million in Q4 2022.
  • The 5-year median for Accumulated Depreciation & Amortization is $10.6 million (2023), against an average of $18.7 million.
  • Year-over-year, Accumulated Depreciation & Amortization plummeted 86.36% in 2023 and then soared 1249.08% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $3.2 million in 2021, then decreased by 13.02% to $2.8 million in 2022, then skyrocketed by 331.14% to $12.1 million in 2023, then rose by 1.89% to $12.3 million in 2024, then skyrocketed by 284.24% to $47.3 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Accumulated Depreciation & Amortization are $47.3 million (Q4 2025), $46.7 million (Q3 2025), and $44.5 million (Q2 2025).